Literature DB >> 20870049

Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.

Joshua D Blazek1, Anna Gaddy, Rachel Meyer, Randall J Roper, Jiliang Li.   

Abstract

Down syndrome (DS) is a genetic disorder resulting from trisomy 21 that causes cognitive impairment, low muscle tone and craniofacial alterations. Morphometric studies of the craniofacial and appendicular skeleton in individuals with DS suggest that bone development and homeostasis are affected by trisomy. The Ts65Dn mouse model has three copies of approximately half the genes found on human chromosome 21 and exhibits craniofacial skeletal and size differences similar to those observed in humans with DS. We hypothesized that Ts65Dn and euploid mice have distinct differences in bone development and homeostasis influencing both the craniofacial and appendicular skeletal phenotypes. Quantitative assessment of structural and mechanical properties of the femur in Ts65Dn and control mice at 6 and 16 weeks of age revealed significant deficiencies in trabecular and cortical bone architecture, bone mineral density, bone formation, and bone strength in trisomic bone. Furthermore, bone mineral density and dynamic dentin formation rate of the skull and incisor, respectively, were also reduced in Ts65Dn mice, demonstrating that trisomy significantly affects both the craniofacial and appendicular skeleton. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20870049      PMCID: PMC3021595          DOI: 10.1016/j.bone.2010.09.028

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  43 in total

1.  A gene expression map of human chromosome 21 orthologues in the mouse.

Authors:  Yorick Gitton; Nadia Dahmane; Sonya Baik; Ariel Ruiz i Altaba; Lorenz Neidhardt; Manuela Scholze; Bernhard G Herrmann; Pascal Kahlem; Alia Benkahla; Sabine Schrinner; Reha Yildirimman; Ralf Herwig; Hans Lehrach; Marie-Laure Yaspo
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

2.  Bone mineral mass in males and females with and without Down syndrome.

Authors:  Fatima Baptista; Ana Varela; Luis B Sardinha
Journal:  Osteoporos Int       Date:  2004-09-09       Impact factor: 4.507

Review 3.  The role of collagen in bone strength.

Authors:  S Viguet-Carrin; P Garnero; P D Delmas
Journal:  Osteoporos Int       Date:  2005-12-09       Impact factor: 4.507

4.  Skeletal age of individuals with Down syndrome.

Authors:  Mari Eli Leonelli de Moraes; Jefferson Luis Oshiro Tanaka; Luis Cesar de Moraes; Edmundo Medici Filho; Julio Cezar de Melo Castilho
Journal:  Spec Care Dentist       Date:  2008 May-Jun

Review 5.  Cell fate determination during tooth development and regeneration.

Authors:  Thimios A Mitsiadis; Daniel Graf
Journal:  Birth Defects Res C Embryo Today       Date:  2009-09

6.  Pattern of malformations in the axial skeleton in human trisomy 21 fetuses.

Authors:  J W Keeling; B F Hansen; I Kjaer
Journal:  Am J Med Genet       Date:  1997-02-11

7.  Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.

Authors:  D M Holtzman; D Santucci; J Kilbridge; J Chua-Couzens; D J Fontana; S E Daniels; R M Johnson; K Chen; Y Sun; E Carlson; E Alleva; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

8.  Microstructure of trabecular bone in a mouse model for Down syndrome.

Authors:  Trish Parsons; Timothy M Ryan; Roger H Reeves; Joan T Richtsmeier
Journal:  Anat Rec (Hoboken)       Date:  2007-04       Impact factor: 2.064

9.  Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone homeostasis.

Authors:  Youngkyun Lee; Jeongim Ha; Hyung Joon Kim; Yeun-Soo Kim; Eun-Ju Chang; Woo-Joo Song; Hong-Hee Kim
Journal:  J Biol Chem       Date:  2009-10-02       Impact factor: 5.157

10.  P2X7 nucleotide receptor plays an important role in callus remodeling during fracture repair.

Authors:  Jiliang Li; Rachel Meyer; Randall L Duncan; Charles H Turner
Journal:  Calcif Tissue Int       Date:  2009-03-24       Impact factor: 4.333

View more
  19 in total

1.  Bone mineral density in adults with Down syndrome.

Authors:  A Carfì; R Liperoti; D Fusco; S Giovannini; V Brandi; D L Vetrano; E Meloni; D Mascia; E R Villani; E Manes Gravina; R Bernabei; G Onder
Journal:  Osteoporos Int       Date:  2017-07-06       Impact factor: 4.507

2.  Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.

Authors:  Megan Stringer; Irushi Abeysekera; Jared Thomas; Jonathan LaCombe; Kailey Stancombe; Robert J Stewart; Karl J Dria; Joseph M Wallace; Charles R Goodlett; Randall J Roper
Journal:  Physiol Behav       Date:  2017-05-03

Review 3.  Aneuploidy and skeletal health.

Authors:  Archana Kamalakar; John R Harris; Kent D McKelvey; Larry J Suva
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

4.  Overlapping trisomies for human chromosome 21 orthologs produce similar effects on skull and brain morphology of Dp(16)1Yey and Ts65Dn mice.

Authors:  John M Starbuck; Tara Dutka; Tabetha S Ratliff; Roger H Reeves; Joan T Richtsmeier
Journal:  Am J Med Genet A       Date:  2014-05-01       Impact factor: 2.802

5.  Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome.

Authors:  Samantha D McElyea; John M Starbuck; Danika M Tumbleson-Brink; Emily Harrington; Joshua D Blazek; Ahmed Ghoneima; Katherine Kula; Randall J Roper
Journal:  Hum Mol Genet       Date:  2016-11-15       Impact factor: 6.150

6.  Low bone turnover and low bone density in a cohort of adults with Down syndrome.

Authors:  K D McKelvey; T W Fowler; N S Akel; J A Kelsay; D Gaddy; G R Wenger; L J Suva
Journal:  Osteoporos Int       Date:  2012-08-18       Impact factor: 4.507

7.  Differential effects of Epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model.

Authors:  Irushi Abeysekera; Jared Thomas; Taxiarchis M Georgiadis; Alycia G Berman; Max A Hammond; Karl J Dria; Joseph M Wallace; Randall J Roper
Journal:  Mol Nutr Food Res       Date:  2016-02-11       Impact factor: 5.914

Review 8.  Skeletal dynamics of Down syndrome: A developing perspective.

Authors:  Jonathan M LaCombe; Randall J Roper
Journal:  Bone       Date:  2019-12-27       Impact factor: 4.398

Review 9.  Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis.

Authors:  Y Zhang; Z Tian; S Ye; Q Mu; X Wang; S Ren; X Hou; W Yu; J Guo
Journal:  Osteoporos Int       Date:  2021-08-12       Impact factor: 4.507

10.  Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment.

Authors:  Tristan W Fowler; Kent D McKelvey; Nisreen S Akel; Jaclyn Vander Schilden; Anthony W Bacon; John W Bracey; Timothy Sowder; Robert A Skinner; Frances L Swain; William R Hogue; Donna B Leblanc; Dana Gaddy; Galen R Wenger; Larry J Suva
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.